<?xml version="1.0" encoding="UTF-8"?>
<svg height="870.031005859375" width="672.0029907226562" xmlns="http://www.w3.org/2000/svg">
 <g style="fill:none;">
  <path d=" M 0.05999799817800522 826.072021484375 L 22.619997024536133 826.072021484375 L 22.619997024536133 826.35546875 L 0.05999799817800522 826.35546875 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 33.67599868774414 837.4110107421875 L 33.959449768066406 837.4110107421875 L 33.959449768066406 860.031005859375 L 33.67599868774414 860.031005859375 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 627.9869995117188 837.4110107421875 L 628.2703857421875 837.4110107421875 L 628.2703857421875 860.031005859375 L 627.9869995117188 860.031005859375 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 639.3259887695312 826.072021484375 L 662.0029907226562 826.072021484375 L 662.0029907226562 826.35546875 L 639.3259887695312 826.35546875 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 639.3259887695312 33.731998443603516 L 662.0029907226562 33.731998443603516 L 662.0029907226562 34.015480041503906 L 639.3259887695312 34.015480041503906 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 627.9869995117188 0.0 L 628.2703857421875 0.0 L 628.2703857421875 22.677000045776367 L 627.9869995117188 22.677000045776367 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 33.67599868774414 0.0 L 33.959449768066406 0.0 L 33.959449768066406 22.677000045776367 L 33.67599868774414 22.677000045776367 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 0.05999799817800522 33.731998443603516 L 22.619997024536133 33.731998443603516 L 22.619997024536133 34.015480041503906 L 0.05999799817800522 34.015480041503906 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <text x="71.887,76.836,79.257,84.206,86.62700000000001,91.105,93.526,98.655,103.604,105.747,110.876,115.359,117.502,122.729,127.858,130.902,135.851,140.98,146.39499999999998,149.383,154.333,158.816,163.765,165.908,171.037,175.52,177.663,182.89,188.01899999999998,191.051,196.001,199.265,201.407,204.295,209.244,212.508,214.651" y="38.61400000000003" svg_rhmargin="219.6" style="fill:#171615;font-family:DPNDHE+AdvOT01861455.I;font-size:8.97px;font-style:NORMAL;font-weight:normal;">2.2. Inclusion and exclusion criteria</text>
  <text x="71.887,77.768,82.718,86.63600000000001,88.667,95.105,101.543,107.425,110.877,112.931,117.88,122.363,127.312,129.315,132.202,137.151,139.18,146.55,150.468,154.386,157.273,159.305,162.192,167.142,171.06,173.081,175.968,180.918,183.339,185.76,190.709,197.613,200.034,204.983,209.466,211.518,215.436,218.888,221.309,224.196,228.115,231.567,233.987,238.47,240.544,243.431,248.38000000000002,250.408,255.358,259.276,261.293,263.714,268.664,272.582,275.003,279.952,284.902,288.82,293.769,295.818,298.239,303.188,305.173,308.06,313.009" y="54.601999999999975" svg_rhmargin="316.927" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">The RCTs had to meet the following criteria to be included in the</text>
  <text x="71.887,76.37,81.319,85.802,88.223,92.706,96.158,98.579,102.031,104.45200000000001,106.411,111.361,115.279,120.228,122.649,127.132,130.584,132.546,137.496,139.917,143.369,147.287,151.77,155.222,159.14,162.59199999999998,164.52,171.424,175.342,178.794,182.71200000000002,184.702,187.589,191.042,194.96,199.443,202.33,206.248,211.197,213.161,220.065,222.486,225.373,230.322,232.267,236.75,241.699,243.606,248.089,253.038,255.925,258.346,261.233,267.671,273.087,279.991,284.94,286.917,291.4,295.884,299.802,304.751,307.638,309.594,312.015" y="65.54399999999998" svg_rhmargin="316.964" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">analysis: ocular diseases were treated with an anti-VEGF agent in</text>
  <text x="71.887,74.774,79.723,83.641,87.647,92.13,97.079,99.966,103.885,107.337,109.758,114.707,118.15899999999999,122.228,125.68,129.598,134.081,141.452,145.37,150.319,153.206,155.62699999999998,159.644,164.594,169.077,172.529,175.416,177.837,181.755,184.176,189.125,193.609,198.558,201.445,204.897,208.965,215.869,219.788,223.24,227.15800000000002,231.132,236.081,240.564,243.451,245.872,249.791,254.74,257.627,261.079,265.146,272.05,277.0,281.949,285.952,289.404,293.322,297.24,301.159,303.579,308.063,311.981" y="76.48500000000001" svg_rhmargin="316.93" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">the anterior segment; participants were patients who received</text>
  <text x="71.887,74.774,79.723,84.673,87.093,91.012,95.495,97.916,100.337,104.597,108.049,112.999,117.948,121.867,126.816,131.765,134.186,139.136,144.085,148.003,150.89,153.311,157.794,162.278,164.699,167.12,171.379,176.329,179.781,184.022,186.443,191.392,194.279,197.731,202.214,206.133,210.616,217.986,221.904,225.356,229.84,232.261,236.518,238.939,243.888,246.309,250.227,254.145,257.033,259.454,264.403,269.35200000000003,273.593,278.543,281.43,285.669,290.152,295.101,299.332,303.815,308.765,311.652,314.073" y="87.48299999999995" svg_rhmargin="316.96" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">topical, subconjunctival, or intracameral injection of an anti-</text>
  <text x="71.887,78.324,83.74,90.644,95.593,97.227,101.71,106.193,110.112,115.061,117.94800000000001,119.62,123.539,128.488,135.858,140.808,145.291,148.743,152.661,157.61,159.247,166.151,168.572,171.459,176.40800000000002,178.126,182.609,184.249,187.701,192.65,197.133,204.50300000000001,206.132,211.081,214.533,216.166,221.115,223.536,228.02,231.938,235.856,240.805,245.75400000000002,247.403,250.29,253.742,257.66,262.143,265.031,272.401,276.319,281.269,284.156,286.577,288.277,292.76,297.709,302.192,306.111,309.563,313.015" y="98.42499999999995" svg_rhmargin="316.933" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">VEGF agent compared with a sham or placebo treatment; adverse</text>
  <text x="71.887,75.805,80.288,84.206,89.156,92.043,95.495,99.155,106.059,109.977,113.429,117.34700000000001,120.924,124.376,128.294,133.244,138.193,141.645,144.532,148.451,153.4,155.821,159.474,163.957,168.906,173.85500000000002,177.502,180.389,185.338,189.256,192.865,196.317,199.204,204.154,209.103,213.586,217.186,222.135,226.053,229.505,231.926,236.409,241.358,245.021,251.925,256.408,259.86,263.502,267.985,271.553,275.005,279.488,284.437,289.387,294.336,301.706,304.127,308.046,311.964" y="109.36699999999996" svg_rhmargin="316.913" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">events were reported; and the study design was a randomized</text>
  <text x="71.887,75.805,80.754,85.704,88.591,92.043,96.992,99.413,101.834,105.752,110.701,113.045,115.932,119.384,121.805,126.288,128.709,131.072,133.493,138.442,140.767,145.716,148.603,152.521,155.973,160.457,164.94,167.361,172.31,179.68,182.038,186.987,190.439,192.809,197.292,199.713,204.196,209.145,213.064,218.013,225.383,229.867,232.28799999999998,234.59,240.472,245.421,249.339,251.711,255.629,260.579,264.497,266.918,271.867,275.319,277.74,282.69,287.639,289.978,293.896,297.348,299.769,302.656,306.574,310.026,312.447" y="120.30799999999999" svg_rhmargin="316.93" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">controlled trial in pterygium or glaucoma. The exclusion criteria</text>
  <text x="71.887,78.791,82.709,86.161,90.07900000000001,91.842,96.325,99.777,101.48,104.367,109.316,111.737,114.158,119.108,126.012,129.464,131.885,133.681,136.568,141.517,145.435,147.173,150.625,153.512,158.462,163.411,167.894,169.623,173.075,176.993,180.445,185.395,187.815,190.703,194.155,195.927,202.831,206.75,210.202,214.12,215.883,220.832,225.781,228.668,230.396,235.345,240.294,245.244,247.665,250.086,253.538,258.487,262.405,267.354,269.116,271.537,276.486,278.187,281.074,286.023,288.444,290.865,293.286,295.081,300.031,304.98,307.867,309.594,312.015" y="131.30600000000004" svg_rhmargin="316.964" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">were as follows: the study results were not published in full, but in</text>
  <text x="71.887,76.37,81.319,86.269,89.721,93.639,98.122,100.543,105.026,107.913,111.831,116.78,118.883,121.771,126.72,130.172,137.542,139.69,143.142,148.091,152.009,156.958,159.078,163.562,167.014,169.113,173.596,178.54500000000002,180.621,185.104,190.053,193.505,196.393,199.845,204.328,208.246,211.133,213.554,215.712,220.195,223.648,226.535,228.956,232.874,235.295,239.213,242.665,244.795,248.247,252.165,257.114,262.064,265.516,268.403,270.824,275.773,280.25600000000003,282.38,285.268,290.217,294.135,296.214,299.666,302.553,307.502,312.452" y="142.24800000000005" svg_rhmargin="316.935" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">abbreviated form such as an abstract; articles reporting the study</text>
  <text x="71.887,75.339,79.257,82.709,87.658,90.079,92.966,96.41799999999999,99.325,103.244,108.193,113.142,116.029,120.513,122.934,127.883,131.801,136.75,139.632,143.084,147.003,151.952,155.87,160.353,163.241,167.159,172.108,174.951,179.9,183.352,186.232,189.684,192.105,199.475,201.896,204.317,208.8,212.252,215.145,220.094,224.577,227.464,231.948,234.369,237.255,242.204,245.656,248.48,250.901,253.788,256.7,264.07,269.02,271.441,274.328,276.749,281.698,284.119,288.03700000000003,290.885,294.337,297.224,302.173,307.123,309.544,313.462" y="153.18899999999996" svg_rhmargin="316.914" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">results contained repeated or similar data; or if multiple studies</text>
  <text x="71.887,76.836,80.754,84.206,88.125,91.577,93.997,98.947,102.865,107.814,110.493,113.38,118.329,122.247,124.836,128.288,132.771,140.142,144.06,146.719,151.669,156.618,161.568,166.517,168.938,173.421,176.308,178.729,183.678,188.628,191.04899999999998,193.716,196.603,201.553,205.471,208.116,211.568,214.455,219.405,224.354,228.83700000000002,231.473,238.377,240.798,243.685,248.63400000000001,251.258,254.146,259.095,263.01300000000003,265.658,273.029,277.978,281.43,284.317,286.974,291.923,295.841,298.729,303.212,305.633,308.054,311.972" y="164.187" svg_rhmargin="316.921" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">described the same population, the study with the most detailed</text>
  <text x="71.887,76.836,81.785,84.673,88.591,93.54,100.91,104.828,107.829,114.733,119.216,122.66799999999999,125.687,130.636,134.089,138.007,142.95600000000002,145.926,150.409,155.358,160.30700000000002,163.33,166.217,171.167,175.085,178.07,183.019,185.907,190.856,194.774,198.226,201.678,204.658,211.562,215.48,218.932,222.85,225.86,229.779,234.728,238.646,241.067,246.017,250.966,254.884,259.834" y="175.12900000000002" svg_rhmargin="262.255" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">outcome was used and the others were excluded.</text>
  <text x="71.887,76.836,79.257,84.206,86.62700000000001,91.105,96.888,99.775,104.904,110.32,114.803,117.807,122.29,127.239,129.382,134.331,139.281,142.168,144.311,149.538" y="201.77499999999998" svg_rhmargin="154.667" style="fill:#171615;font-family:DPNDHE+AdvOT01861455.I;font-size:8.97px;font-style:NORMAL;font-weight:normal;">2.3. Study selection</text>
  <text x="71.887,77.768,84.673,89.622,96.435,99.887,103.805,108.288,110.709,114.627,121.531,125.449,128.902,132.35399999999998,139.18,143.098,148.047,152.997,157.946,162.895,166.814,169.701,173.619,178.568,185.383,187.804,192.753,197.703,201.621,206.57,210.489,215.438,220.387,224.306,229.255,232.142,238.956,243.439,246.891,250.343,254.261,257.713,261.165,268.536,272.454,277.403,280.29,283.742,290.544,295.494,298.38100000000003,305.171,308.058,313.008" y="217.70500000000004" svg_rhmargin="316.926" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Two reviewers conducted independent assessments of the</text>
  <text x="71.887,75.339,79.257,82.709,86.627,91.11,94.562,98.481,103.42999999999999,105.278,108.73,112.648,116.1,121.05,123.471,126.358,129.81,131.639,136.588,141.071,142.864,147.347,152.296,156.78,159.2,163.684,167.602,170.023,174.972,179.455,181.301,184.188,189.137,193.055,194.85,197.737,200.158,203.045,205.466,209.384,212.83599999999998,214.691,219.174,224.124,229.073,230.905,235.388,240.337,243.789,246.677,250.129,254.612,258.53,261.417,264.86899999999997,266.677,271.16,276.109,281.058,282.891,287.374,290.826,294.278,298.196,301.648,305.1,307.521,312.47" y="228.70299999999997" svg_rhmargin="316.953" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">research results by analyzing the titles and abstracts and assessing</text>
  <text svg_rhmargin="205.81" x="71.887,74.774,79.723,83.641,85.946,89.398,93.316,95.737,99.655,104.138,108.622,113.571,116.458,118.713,121.6,126.55,128.971,131.391,134.279,137.166,141.084,146.033,148.92,151.254,155.737,159.189,162.076,164.497,168.415,170.836,174.754,178.206,180.506,183.393,188.343,191.795,194.055,196.942,201.892,205.81" y="239.64499999999998" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">the relevant full-text articles for the </text>
  <text x="208.121" y="239.64499999999998" svg_rhmargin="213.07" style="fill:#171615;font-family:DPNDHD+AdvOTbc475f09+fb;font-size:8.97px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="213.053,218.002,222.485,224.906,227.226,230.678,234.596,237.017,240.935,244.854,247.741,250.162,255.111,260.061,262.48199999999997,264.755,271.659,274.08,277.532,281.451,284.903,288.821,293.77,298.253,303.203,307.121,309.542,313.46" y="239.64499999999998" svg_rhmargin="316.912" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">nal selection. Discrepancies</text>
  <text x="71.887,78.791,82.709,86.161,90.07900000000001,93.089,96.541,100.46,103.912,108.861,111.282,115.765,119.683,124.632,127.614,132.563,137.046,140.03,143.948,148.897,153.847,157.299,162.248,164.669,167.556,169.977,174.926,179.409,182.435,186.918,189.918,192.805,197.755,200.176,203.628,208.577,211.574,215.026,218.945,223.428,225.849,229.767,236.671,240.589,244.041,247.063,249.95,256.854,260.306,263.333,267.816,274.254,280.692,283.579" y="250.587" svg_rhmargin="286.0" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">were resolved by consulting a third reviewer (Dr SYZ).</text>
  <text x="71.887,76.836,79.257,84.206,86.62700000000001,91.105,97.543,102.492,105.379,110.328,113.328,118.277,122.76,125.648,128.911,133.861,138.81,141.697,143.84,149.068,154.197,157.207,162.157,167.285,172.7,175.745,179.009,181.152,185.635,190.208,193.206,198.433,201.23,204.204,209.62,211.763,216.712,221.195,224.216,229.165,233.649,238.132,243.081,247.564,252.047,259.983,264.932,270.061" y="277.23299999999995" svg_rhmargin="272.948" style="fill:#171615;font-family:DPNDHE+AdvOT01861455.I;font-size:8.97px;font-style:NORMAL;font-weight:normal;">2.4. Data extraction and risk of bias assessment</text>
  <text x="71.887,77.768,82.718,86.63600000000001,91.786,96.735,101.934,105.386,109.304,113.787,116.208,120.126,127.03,130.949,134.401,137.853,143.034,145.455,150.404,155.354,159.272,164.222,168.14,173.089,178.039,181.957,186.906,189.793,192.214,196.697,201.879,205.797,210.747,213.634,217.086,221.569,225.487,228.375,232.293,237.24200000000002,242.47,245.358,250.307,254.225,259.365,264.314,268.797,271.685,276.168,281.361,284.248,287.7,292.65,300.02,305.172,308.059,313.008" y="293.163" svg_rhmargin="316.926" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">The 2 reviewers independently extracted the data from the</text>
  <text x="71.887,74.307,79.257,83.175,85.596,90.545,95.495,99.413,104.362,107.546,110.998,113.885,118.834,123.784,126.204,130.123,133.575,136.798,143.702,146.123,149.01,153.959,157.151,160.038,164.987,168.905,172.117,175.569,180.052,187.423,191.341,194.511,196.931,201.881,205.799,208.22,213.169,216.621,219.042,223.992,228.941,232.154,236.072,239.524,241.945,244.832,248.75,252.202,254.623,259.107,261.528,264.751,271.655,274.076,277.528,281.446,284.898,288.816,293.766,298.249,303.198,307.117,309.537,313.456" y="304.161" svg_rhmargin="316.908" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">included studies with the same inclusion criteria. Discrepancies</text>
  <text x="71.887,78.791,82.709,86.161,90.07900000000001,92.636,96.088,100.006,103.458,108.407,110.828,115.311,119.23,124.179,126.707,129.127,134.07600000000002,136.571,140.49,145.439,150.388,153.84,158.79,161.211,164.098,168.581,171.468,173.889,178.838,183.787,186.346,193.25,195.671,198.558,203.507,206.074,208.962,213.911,217.829,220.304,223.191,228.141,230.561,234.013,238.96200000000002,241.507,244.959,248.877,253.36,255.781,259.699,266.603,270.522,273.974,276.395,278.979,284.861,289.811,293.729,296.214,299.666,302.553,307.502,312.452" y="315.103" svg_rhmargin="316.935" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">were resolved in consultation with the third reviewer. The study</text>
  <text x="71.887,75.805,80.754,85.237,88.689,93.173,97.091,99.978,103.896,107.348,109.769,113.221,116.108,118.529,122.448,125.9,128.321,132.659,135.08,140.03,143.948,146.369,151.318,156.268,158.688,163.638,168.121,172.456,175.343,180.293,184.211,188.5,191.952,194.839,199.788,204.738,209.221,213.5,218.45,222.368,225.82,228.241,232.724,237.674,240.095,244.397,249.347,253.83,257.282,260.169,262.59,266.508,268.929,273.879,278.362,283.311,286.198,289.65,292.07099999999997,296.44,298.86,303.81,306.697,310.615,314.067" y="326.044" svg_rhmargin="316.954" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">characteristics, including the study design, participants, inter-</text>
  <text x="71.887,76.37,80.288,85.237,88.125,90.545,95.495,100.444,103.896,106.31700000000001,109.133,112.02,116.969,119.39,121.811,126.76,133.664,136.552,141.501,146.45000000000002,149.327,152.214,154.635,162.005,165.923,168.344,171.152,175.636,180.585,185.53400000000002,188.387,192.305,197.254,204.625,209.574,211.995,214.416,218.334,222.817,225.704,228.125,233.075,238.024,241.476,243.897,246.721,253.625,257.544,260.996,264.914,267.754,272.703,277.652,281.571,286.52,293.89,297.809,302.758,305.645,309.563,314.513" y="337.042" svg_rhmargin="316.934" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">ventions, follow-up time, and complications, were documented.</text>
  <text x="71.887,77.768,82.718,86.63600000000001,88.95,95.388,100.338,104.256,109.205,112.657,117.14,122.09,126.00800000000001,128.351,134.789,137.21,140.662,145.61100000000002,147.967,152.916,155.803,158.115,163.53,165.951,170.434,173.886,176.199,182.081,187.03,191.979,194.4,196.777,203.681,208.165,211.617,213.898,218.848,222.3,226.218,231.167,233.514,236.401,241.35000000000002,243.662,247.58,252.064,256.547,258.968,263.917,268.4,271.287,275.205,277.564,282.513,284.934,289.417,292.86899999999997,295.195,300.144,304.628,308.08,311.998" y="347.984" svg_rhmargin="316.947" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">The Cochrane Risk of Bias Tool was used to evaluate bias based</text>
  <text x="71.887,76.836,81.785,85.21,88.097,93.046,96.96400000000001,100.347,103.234,108.183,110.604,113.025,117.974,124.878,127.299,132.249,136.732,139.153,142.638,146.09,150.008,154.958,159.907,163.825,168.775,172.693,176.61100000000002,179.997,184.48,188.398,193.348,197.266,200.718,205.201,208.088,210.509,215.459,220.40800000000002,223.875,228.358,233.308,238.257,241.62,246.103,248.524,250.945,255.894,259.812,264.295,267.182,269.603,274.553,279.502,282.947,286.399,290.317,295.267,300.216,304.134,309.084,313.002" y="358.926" svg_rhmargin="316.92" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">on the following: sequence generation and allocation sequence</text>
  <text x="71.887,75.805,80.754,85.704,89.622,93.54,98.023,100.444,107.815,111.733,116.682,119.569,124.439,127.326,131.809,135.261,140.143,143.595,147.513,149.934,153.852,157.77,160.657,163.078,168.028,172.977,177.842,182.792,185.213,189.696,193.148,196.035,198.456,203.353,208.303,210.723,213.144,218.094,223.043,225.464,230.413,234.89600000000002,239.749,244.699,247.586,252.448,257.398,261.881,265.333,268.22,270.641,274.559,276.98,281.929,286.413,291.362,294.249,297.701,302.563,307.046,311.995" y="369.924" svg_rhmargin="316.944" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">concealment (as selection bias), blinding of participants and</text>
  <text x="71.887,76.836,80.754,84.206,87.658,92.608,97.557,102.507,106.425,108.846,110.607,113.494,118.443,122.361,125.813,128.701,133.65,137.102,144.472,148.956,153.905,157.823,161.741,163.556,168.506,170.927,175.41,178.862,181.749,184.17,185.95,188.37,193.32,197.238,202.188,209.558,214.507,216.928,220.846,223.734,227.65200000000002,229.432,234.381,239.33,242.218,246.136,251.085,258.456,262.374,264.127,269.076,273.559,276.446,280.92900000000003,282.665,285.552,290.035,292.922,295.809,299.261,301.682,304.569,306.99,311.94" y="380.865" svg_rhmargin="316.889" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">personnel (performance bias), incomplete outcome data (attrition</text>
  <text svg_rhmargin="316.906" x="71.887,76.836,79.257,83.74,87.192,90.079,92.5,95.98,99.432,103.35,105.771,109.689,113.608,116.495,118.916,123.399,127.31700000000001,130.845,134.297,138.216,143.165,148.114,151.567,154.454,156.875,161.824,166.30700000000002,169.792,172.679,176.131,180.05,184.999,189.949,193.401,196.288,198.709,203.658,208.141,211.63,216.579,219.0,223.483,226.935,229.823,232.244,235.781,238.668,243.617,248.567,253.516,255.937,260.886,265.369,268.831,271.719,276.668,280.12,283.628,286.515,291.464,295.382,298.821,301.708,305.16,307.581,312.064,314.485,316.906" y="39.74199999999996" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">bias), selective reporting (reporting bias), funding for the trial, </text>
  <text svg_rhmargin="346.32" x="331.938,336.421,341.371,346.32" y="39.74199999999996" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">and </text>
  <text x="348.492" y="39.74199999999996" svg_rhmargin="353.441" style="fill:#171615;font-family:DPNDHD+AdvOTbc475f09+fb;font-size:8.97px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="353.425,358.374,362.857,367.807,371.725,374.146,378.629,381.05,383.244,386.696,390.614,393.035,397.518,400.406,402.826,407.776,412.725,416.177,421.127,423.548,428.497,430.751,434.203,438.121,443.071,448.02,451.472,454.359,458.278,463.22700000000003,465.446,470.396,474.879,477.068,479.956,484.905,488.823,491.015,495.498,500.447,503.334,508.284,513.233,516.685,520.137,522.558,524.802,531.706,534.127,537.579,541.497,544.95,548.868,553.817,558.3,563.25,567.168,569.589,573.507" y="39.74199999999996" svg_rhmargin="576.959" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">nancial relationship reported by the authors. Discrepancies</text>
  <text x="331.938,338.842,342.76,346.212,350.13,353.084,356.536,360.454,363.906,368.856,371.277,375.76,379.678,384.627,387.665,392.615,397.098,400.081,402.968,407.918,411.836,414.821,417.708,422.657,425.078,428.53,433.479,436.477,439.929,443.847,448.33,450.751,454.67,461.574,465.492,468.944" y="50.68399999999997" svg_rhmargin="471.365" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">were resolved by the third reviewer.</text>
  <text x="331.938,336.887,339.308,344.258,346.679,351.156,357.594,362.544,365.431,370.38,373.379,377.863,382.346,387.474,390.362,395.49,400.44,404.923,407.066,411.549,414.537,419.487,424.616,430.031,433.019,437.502,440.389,445.338,448.226,450.369,454.852,457.739,459.882,464.831,469.781,471.924,474.97,479.92,485.048,489.998,492.141,496.624,501.107,503.25" y="77.33000000000004" svg_rhmargin="507.733" style="fill:#171615;font-family:DPNDHE+AdvOT01861455.I;font-size:8.97px;font-style:NORMAL;font-weight:normal;">2.5. Data synthesis and statistical analysis</text>
  <text x="331.938,334.825,340.241,349.207,351.1,355.583,360.532,365.016,369.499,371.453,376.402,381.351,383.772,388.721,390.671,394.123,399.072,401.959,404.847,411.751,416.234,419.686,423.604,425.535,432.44,436.923,440.375,442.316,447.265,450.717,454.636,459.58500000000004,461.534,464.421,469.37,471.285,475.768,480.718,485.201,487.622,492.105,496.023,499.94100000000003,501.898,504.785,509.734,513.6519999999999,515.617,520.567,525.05,527.937,532.42,534.325,538.244,543.193,545.614,548.035,551.953,555.871,558.759,562.677,567.626,569.587,572.008" y="93.25999999999999" svg_rhmargin="576.957" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">IBM SPSS 20.0 software was used to analyze the data collected in</text>
  <text svg_rhmargin="381.235" x="331.938,334.825,339.775,342.195,345.647,348.605,352.057,354.945,359.894,364.843,369.327,371.748,374.797,381.235" y="104.25900000000001" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">this study. A </text>
  <text svg_rhmargin="389.625" x="384.209,389.624" y="104.25900000000001" style="fill:#171615;font-family:DPNDOJ+AdvOT638a931c.I;font-size:8.97px;font-style:NORMAL;font-weight:normal;">P </text>
  <text x="392.599,397.083,401.566,403.987,408.936,412.854,415.843,418.264,422.182,425.634,429.086,432.113,435.0,439.95,444.433,449.382,451.803,456.752,461.701,464.711,471.615,476.098,479.55,482.512,487.461" y="104.25900000000001" svg_rhmargin="491.379" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">value less than.05 was de</text>
  <text x="491.415" y="104.25900000000001" svg_rhmargin="496.364" style="fill:#171615;font-family:DPNDHD+AdvOTbc475f09+fb;font-size:8.97px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="496.348,501.297,505.215,510.164,513.185,517.669,521.121,524.071,527.523,529.943,534.427,539.376" y="104.25900000000001" svg_rhmargin="541.797" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">ned as signi</text>
  <text x="541.816" y="104.25900000000001" svg_rhmargin="546.765" style="fill:#171615;font-family:DPNDHD+AdvOTbc475f09+fb;font-size:8.97px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="546.805,550.723,555.206,560.155,563.043" y="104.25900000000001" svg_rhmargin="565.464" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">cant.</text>
  <text x="340.895,346.777,351.727,355.645,359.943,364.893,368.345,370.766,378.136,382.619,386.071,390.55400000000003,394.922,399.871,404.821,407.708,411.626,416.575,423.946,427.86400000000003,432.168,439.072,443.555,447.007,451.386,454.273,459.223,463.141,467.43,472.379,475.831,480.78,485.73,490.679,494.131,497.018,499.439,504.389,509.338,513.689,518.639,521.526,525.878,530.828,535.311,538.198,540.619,544.537,549.487,552.374,555.826,560.176,567.08,572.03" y="115.20000000000005" svg_rhmargin="576.979" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">The primary outcome was the proportion of patients who</text>
  <text x="331.938,335.856,340.806,345.755,349.673,353.125,355.546,359.465,364.414,368.332,372.25,377.199,381.883,386.366,391.315,395.943,400.892,404.811,409.76,412.181,416.664,420.116,424.799,429.282,434.232,437.119,441.037,444.489,446.91,451.86,455.312,460.005,463.457,467.375,471.858,479.228,483.147,488.096,490.983,495.664,500.147,505.096,509.579,513.498,516.95,520.402,524.32,528.998,532.917,537.4,541.318,546.268,549.155,551.576,556.267,563.637,568.586,573.536" y="126.14200000000005" svg_rhmargin="576.988" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">experienced an ocular anterior segment adverse event. Odds</text>
  <text x="331.938,335.39,339.873,342.76,345.181,350.131,353.58299999999997,355.579,358.466,365.836,372.274,375.726,378.613,380.692,387.596,390.017,392.904,397.853,399.911,404.86,409.809,418.77500000000003,420.773,424.692,429.641" y="137.14" svg_rhmargin="434.59" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">ratios [ORs] with 95% con</text>
  <text x="434.609" y="137.14" svg_rhmargin="439.558" style="fill:#171615;font-family:DPNDHD+AdvOTbc475f09+fb;font-size:8.97px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="439.542,444.491,448.409,453.359,457.277,461.195,463.239,465.66,470.609,473.496,477.414,480.866,485.35,489.833,492.254,495.706,497.763,500.651,507.088,509.976,513.428,516.3149999999999,518.399,525.303,529.222,532.674,536.592,538.638,542.556,547.04,549.46,553.379,558.328,560.749,565.232,568.119,572.038" y="137.14" svg_rhmargin="576.987" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">dence intervals (CIs) were calculated</text>
  <text x="331.938,334.825,339.774,342.426,346.344,350.827,355.31,357.731,362.681,367.164,370.051,373.969,376.724,379.611,384.56,388.478,391.18,394.632,399.115,402.003,405.921,408.808,413.291,416.011,420.96,423.847,426.498,429.386,432.838,436.756,441.239,444.126,451.496,455.415,460.364,463.251,465.67199999999997,468.45,472.933,477.883,482.832,487.315,490.767,495.717,500.666,505.615,508.303,512.787,517.736,522.219,524.64,529.123,532.575,536.493,539.945,542.658,547.607,552.09,555.542,559.461,564.41,567.092,572.041" y="148.08100000000002" svg_rhmargin="576.99" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">to evaluate the safety of treatment. Subgroup analyses based on</text>
  <text x="331.938,336.887,339.308,342.195,345.083,349.001,352.453,356.371,361.321,364.208,368.05,375.42,379.338,384.288,386.709,390.627,395.11,397.997,400.418,405.368,410.317,414.139,417.591,422.541,427.49,430.377,434.296,437.748,441.578,446.527,449.979,453.767,458.716,463.666,467.118,471.601,476.084,480.002,483.87,488.82,491.707,495.492,498.38,503.329,507.247,511.083,515.566,520.516,523.403,525.824,528.711,535.148,540.564,547.468,552.4169999999999,556.266,560.749,565.232,569.151,574.1" y="159.02300000000002" svg_rhmargin="576.987" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">different medication routes or dosage of the anti-VEGF agent</text>
  <text x="331.938,338.842,342.76,346.212,350.13,351.95,356.899,360.818,364.27,367.157,372.106,375.558,382.928,386.847,391.796,393.675,396.562,401.511,403.313,407.231,412.18,419.55,424.5,428.983,432.435,436.353,438.234,441.122,446.071,449.98900000000003,451.841,456.324,461.273,464.161,466.581,469.469,475.906,481.322,488.226,493.175,495.04,499.523,502.975,507.924,512.874,517.823,519.644,524.127,529.077,534.026,535.858,538.745,543.694,547.612,549.464,553.382,558.332,563.281,566.168,569.62,574.57" y="170.02099999999996" svg_rhmargin="576.991" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">were performed to compare the anti-VEGF group and the control</text>
  <text x="331.938,336.421,339.873,344.823,349.772,354.721" y="180.96299999999997" svg_rhmargin="357.142" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">group.</text>
  <text x="340.895,346.777,351.727,355.645,359.491,363.974,368.457,371.909,374.33,378.813,383.762,386.183,388.604,391.025,393.912,398.395,402.292,404.713,409.66200000000003,413.517,418.466,422.385,425.272,429.19,432.642,437.592,442.075,445.993,450.942,454.861,457.282,460.169,464.652,468.564,473.513,476.4,480.242,483.13,488.079,491.997,495.89,498.31,503.26,507.178,509.599,514.548,519.498,523.416,528.365,532.228,535.68,538.567,543.517,548.466,550.887,554.805,558.257,562.161,569.065,573.548" y="191.904" svg_rhmargin="577.0" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">The variability in heterogeneity of the included studies was</text>
  <text x="331.938,336.421,339.873,343.325,347.243,350.696,354.148,358.066,363.015,367.427,372.376,376.859,380.311,384.229,389.178,393.562,398.511,403.46000000000004,407.905,410.792,415.742,419.66,424.062,426.949,431.899,434.32,436.741,441.69,448.594,451.015,455.964,460.447,464.88,468.798,473.747,478.23,481.682,486.166,490.084,492.971,496.889,500.341,502.762,506.214,509.101,511.522,515.441,518.893,521.3140000000001,525.765,530.248,534.732,538.184,540.604,545.088,550.037,552.458,554.879,557.3,560.187,564.67,569.134,574.084" y="202.846" svg_rhmargin="576.971" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">assessed based on the following characteristics: variability of</text>
  <text x="331.938,336.887,341.371,344.823,347.71,350.131,354.049,356.47,361.419,365.902,370.852,373.739,377.191,379.61199999999997,382.846,385.267,390.216,393.103,397.022,400.474,404.957,408.875,413.825,416.712,419.133,424.082,429.031,432.483,434.904,438.176,443.126,448.075,450.962,454.88,459.83,467.2,471.118,474.57,476.991,480.241,483.693,486.58,491.529,496.479,500.962,504.221,509.17,513.089,516.541,518.962,523.445,528.394,530.815,534.04,538.523,543.473,548.4219999999999,551.615,555.067,557.488,560.94,565.889,569.133,574.082" y="213.84400000000005" svg_rhmargin="576.969" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">participants, interventions, outcomes, study design, and risk of</text>
  <text svg_rhmargin="415.748" x="331.938,336.887,339.308,343.791,347.243,349.664,353.651,356.538,361.487,365.5,369.983,374.932,379.882,382.303,385.19,387.611,392.56,397.509,399.93,403.993,406.88,411.83,415.748" y="224.78499999999997" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">bias. In addition, the </text>
  <text x="419.756" y="224.78499999999997" svg_rhmargin="423.208" style="fill:#171615;font-family:DPNDOJ+AdvOT638a931c.I;font-size:8.97px;font-style:NORMAL;font-weight:normal;">I</text>
  <text svg_rhmargin="426.924" x="423.212,426.924" y="224.79399999999998" style="fill:#171615;font-family:DPNDOJ+AdvOT638a931c.I;font-size:5.98px;font-style:NORMAL;font-weight:normal;">2 </text>
  <text x="430.979,435.463,439.946,442.367,447.316,451.234,455.243,462.147,466.63,470.082,474.065,479.015,482.467,486.385,491.334,495.382,498.269,503.218,507.231,509.652,514.601,519.55,521.971,525.889,530.373,533.26,537.178,541.245,544.697,547.584,552.068,554.955,557.376,560.828,563.715,566.136,570.054,574.537" y="224.79399999999998" svg_rhmargin="576.958" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">value was used to indicate statistical</text>
  <text svg_rhmargin="426.624" x="331.937,336.886,340.804,343.692,347.61,351.062,356.011,360.494,364.413,369.362,373.28,375.701,378.588,383.072,385.493,387.721,394.159,396.338,400.821,405.304,407.725,412.675,416.593,418.788,423.737,426.624" y="235.735" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">heterogeneity. A value of </text>
  <text x="428.826" y="235.735" svg_rhmargin="432.278" style="fill:#171615;font-family:DPNDOJ+AdvOT638a931c.I;font-size:8.97px;font-style:NORMAL;font-weight:normal;">I</text>
  <text svg_rhmargin="435.995" x="432.283,435.995" y="235.735" style="fill:#171615;font-family:DPNDOJ+AdvOT638a931c.I;font-size:5.98px;font-style:NORMAL;font-weight:normal;">2 </text>
  <text x="438.179,440.6,445.55,452.454,456.372,459.824,462.047,464.934,469.883,474.367,479.31600000000003,481.492,486.441,491.391,500.357,502.582,509.486,513.969,517.421,519.589,523.507,528.457,533.406,536.858,539.279,544.228,548.147,551.599,555.517,560.466,562.73,565.151,570.101" y="235.735" svg_rhmargin="577.005" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">lower than 50% was considered low</text>
  <text x="331.937,336.886,340.805,343.692,347.61,351.062,356.011,360.495,364.413,369.362,373.28,375.701,378.589,383.072,385.493,388.911,393.394,396.848,401.332,405.815,408.236,413.185,417.103,420.545,425.495,429.413,432.3,439.204,443.123,447.041,451.99,455.411,460.36,465.31,474.276,477.691,482.174,487.124,492.07300000000004,495.549,500.499,505.448,514.414,517.83,524.734,529.217,532.669,536.084,540.003,544.952,549.901,553.353,555.774,560.724,564.642,568.094,572.012" y="246.73400000000004" svg_rhmargin="576.961" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">heterogeneity, a value between 50% and 75% was considered</text>
  <text x="331.937,339.307,344.257,349.206,353.124,356.576,361.059,363.947,367.865,370.316,375.266,379.184,382.071,385.989,389.441,394.391,398.874,402.792,407.742,411.66,414.081,416.968,421.451,423.872,426.327,430.81,435.759,440.708,443.165,447.648,450.081,454.564,459.048,461.469,466.418,470.336,472.814,477.298,480.75,484.668,489.151,492.038,495.957,499.409,501.84,504.727,509.677,514.16,519.1089999999999,521.569,526.518,531.468,540.434,542.885,549.789,554.273,557.725,560.176,565.125,567.546,572.029" y="257.67499999999995" svg_rhmargin="576.978" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">moderate heterogeneity, and a value greater than 75% was high</text>
  <text svg_rhmargin="393.705" x="331.937,336.886,340.805,343.692,347.61,351.062,356.011,360.495,364.413,369.362,373.28,375.701,378.589,383.072,385.493,387.267,393.705" y="268.61699999999996" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">heterogeneity. A </text>
  <text x="395.49" y="268.61699999999996" svg_rhmargin="400.439" style="fill:#171615;font-family:DPNDHD+AdvOTbc475f09+fb;font-size:8.97px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="400.422,405.372,409.29,414.239,417.127,421.045,423.932,426.819,430.737,434.656,437.543,440.995,442.827,450.197,455.146,460.096,464.014,466.435,468.167,475.071,479.554,483.006,484.778,489.728,493.18,497.098,502.047,503.826,506.713,511.66200000000003,513.408,517.891,521.343,524.795,528.713,532.165,535.617,537.388,540.275,545.225,549.143,550.937,554.389,557.276,562.226,567.175,569.596,573.514" y="268.61699999999996" svg_rhmargin="576.966" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">xed-effects model was used to assess the studies</text>
  <text x="331.937,338.841,341.262,344.149,349.098,351.099,353.52,358.469,365.373,367.369,372.318,376.237,379.124,383.042,386.494,391.444,395.927,399.845,404.794,408.713,411.134,414.021,418.504,420.925,422.982,427.466,432.415,437.36400000000003,439.367,443.85,445.886,449.338,453.821,458.771,463.72,468.669,476.039,478.03,481.948,484.836,487.723,491.641,495.559,498.446,501.898,503.938,511.309,516.258,521.207,525.126,527.547,529.562,536.466,540.949,544.401,546.399,551.349,554.801,558.719,563.668,565.674,568.561,573.51" y="279.615" svg_rhmargin="576.962" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">with low heterogeneity, and a random effects model was used for</text>
  <text x="331.937,334.824,339.773,343.69100000000003,346.677,351.626,354.513,359.462,363.381,366.83299999999997,369.807,373.259,376.146,381.095,386.045,388.466,392.384,395.836" y="290.556" svg_rhmargin="398.257" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">the other studies.</text>
  <text x="340.894,346.31,350.793,353.214,358.163,362.082,367.031,370.949,374.867,382.506,387.455,392.405,396.888,399.309,401.73,404.617,409.1,416.805,421.288,424.74,428.192,432.11,435.562,439.014,446.385,450.303,455.252,458.139,465.842,470.792,473.679,481.376,484.264,489.213,491.634,495.086,502.749,510.12,514.038,516.925,521.408,524.295,528.779,533.728,538.211,540.632,545.115,548.567,550.988,554.44,562.162,569.066,573.549" y="301.498" svg_rhmargin="577.001" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Evidence quality assessment of this meta-analysis was</text>
  <text x="331.937,336.886,340.805,344.257,347.144,352.093,355.545,362.915,366.834,371.783,377.913,382.396,386.315,390.233,395.182,398.634,403.584,406.005,410.954,415.437,421.566,424.453,429.402,435.512,438.399,443.349,447.267,453.37,458.32,461.772,465.69,468.577,472.495,475.947,479.399,483.318,488.267,494.414,500.852,504.77,509.72,514.669,518.121,521.008,523.429,528.379,532.862,539.031,541.918,544.805,548.723,556.094,559.546,565.676,568.563,573.512" y="312.44" svg_rhmargin="576.964" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">performed according to the Preferred Reporting Items for</text>
  <text x="331.937,336.42,340.903,344.355,347.242,351.161,358.531,363.014,365.901,368.322,372.24,375.249,381.686,385.605,390.088,392.509,396.427,403.331,406.783,409.773,414.256,419.206,424.15500000000003,427.178,436.144,440.062,442.95,447.433,450.32,454.803,459.752,464.236,466.656,471.14,474.592,477.013,480.465" y="323.438" svg_rhmargin="482.886" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Systematic Reviews and Meta-analysis.</text>
  <text x="331.937,337.852,340.80499999999995,345.486,352.282,357.999,363.223,369.138,371.893,375.536" y="347.08" svg_rhmargin="380.76" style="fill:#171615;font-family:DPNDFJ+AdvOTfbba3ace.B;font-size:9.46px;font-style:NORMAL;font-weight:normal;">3. Results</text>
  <text x="331.937,336.886,339.307,344.257,346.678,351.155,357.405,362.354,366.837,371.966,374.109,376.996,380.012,385.239,388.036,391.01,395.493,400.442,405.392,408.655,413.605" y="364.995" svg_rhmargin="418.734" style="fill:#171615;font-family:DPNDHE+AdvOT01861455.I;font-size:8.97px;font-style:NORMAL;font-weight:normal;">3.1. Result of search</text>
  <text x="331.937,337.819,342.768,346.686,348.661,353.61,357.062,362.012,365.93,369.848,373.3,376.752,378.821,383.77,386.657,388.685,392.138,396.056,398.477,402.395,406.313,409.2,411.621,416.571,421.52000000000004,423.55,426.437,431.387,434.839,436.872,439.293,444.242,448.161,450.582,455.531,458.983,461.404,466.353,471.302,473.381,478.331,481.218,483.246,488.195,491.647,494.068,498.551,500.972,505.922,510.405,512.826,514.879,519.362,522.814,525.701,528.122,532.041,534.461,538.38,541.832,543.848,546.269,549.721,551.785,555.237,560.187,565.136,572.04" y="380.983" svg_rhmargin="576.989" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">The process of selection for inclusion of original articles is shown</text>
  <text x="331.937,334.358,339.307,342.822,347.771,350.192,354.675,357.096,360.68,365.63,368.051,371.622,377.504,382.453,386.371,389.933,393.851,396.272,400.19,404.108,406.996,410.448,415.397,420.346,422.767,426.685,430.24,433.692,437.61,442.093,445.545,449.464,454.413,458.018,462.968,467.91700000000003,471.454,474.906,479.856,484.805,488.723,492.26,497.209,499.63,503.201,508.151,513.1,518.05,522.9989999999999,526.559,531.042,533.463,537.381,539.802,544.751,548.669,553.6179999999999,557.172,562.122,567.071,572.02" y="391.925" svg_rhmargin="576.969" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">in Fig. 1. The electronic search on June 1, 2016 yielded 1174</text>
  <path d=" M 71.88700103759766 383.0740051269531 L 576.9639892578125 383.0740051269531 L 576.9639892578125 383.8110046386719 L 71.88700103759766 383.8110046386719 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 71.88700103759766 84.302001953125 L 576.9639892578125 84.302001953125 L 576.9639892578125 85.03903198242188 L 71.88700103759766 85.03903198242188 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <rect style="stroke:blue;stroke-width:0.3;" x="131.414" y="424.012" height="264.019" width="386.022" title="2"/>
  <text x="131.414" y="424.012" class="image" id="image.2.1" width="386" height="264">image.2.1.131_517.424_688</text>
  <text svg_rhmargin="101.275" x="71.887,76.243,78.03,82.387,86.661,89.225,93.35,95.133,99.258,101.27499999999999" y="699.03" style="fill:#171615;font-family:DPNDMJ+AdvOTf94803d4;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Figure 1. </text>
  <text x="104.995,108.962,110.285,114.409,119.931,123.816,127.783,131.594,133.925,136.09900000000002,137.818,141.942,143.81,145.584,149.395,151.726,153.9,155.223,159.033,160.356,164.167,165.935,169.514,173.325,174.647,178.458,182.268,184.443,185.765,189.89,193.85799999999998,195.64,197.508,201.632,203.963,205.731,209.31,212.732,216.311,218.485,222.296,228.437,232.248,234.422,235.745,239.556,241.331,243.662,247.473,250.895,252.217,256.028,261.55,263.326,267.137,271.104,275.378,277.159,283.301,287.112,289.286,293.097,295.817,299.627,303.595,307.405,308.728,312.15,315.821,317.143,320.722,322.453,324.628,328.753,330.504,334.314,337.893,341.472,345.283,348.862,352.44100000000003,354.2,356.374,360.341,364.152,365.878,369.457,373.268,375.135,378.946,381.12,384.54200000000003,386.342,390.467,392.335,394.053,397.863,402.137,406.411,407.733,411.155,412.478,416.446,420.571,422.397,426.208,430.176,432.35,433.672,437.095,440.905,444.484,448.295,452.262,453.585,457.395,459.726,461.512,465.323,469.29,473.564,477.689,479.863,483.831,487.641,488.964,490.286,494.097,495.41999999999996,497.225,501.35,503.681,507.805,513.327,515.501,519.4689999999999,521.261,523.129,526.94,530.75,532.925,537.049,539.38,541.103,542.888,546.699,550.696,552.87,554.193,556.913,561.269,565.625,571.234,575.201" y="699.03" svg_rhmargin="576.987" style="fill:#171615;font-family:DPNDFL+AdvOT6e5d2ec0;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Flowchart of article selection for systematic review and meta-analysis to assess the safety of applying antivascular endothelial growth factor (anti-VEGF)</text>
  <text x="71.887,75.697,79.822,83.632,87.6,89.774,93.353,95.866,97.188,101.156,103.69,105.864,109.831,113.642,116.105,120.23,124.041,128.008,129.331,133.141,135.47199999999998,138.044,141.855,145.822,147.997,151.807,154.138,155.461,159.585,161.916,164.404,167.983,171.794,175.918,182.06,185.945,189.913,192.087" y="707.987" svg_rhmargin="194.104" style="fill:#171615;font-family:DPNDFL+AdvOT6e5d2ec0;font-size:7.47px;font-style:NORMAL;font-weight:normal;">agents in the ocular anterior segment.</text>
  <text svg_rhmargin="193.001" x="71.887,77.442,81.674,85.739,89.971,94.37,97.001,101.066,103.385,106.015,110.08,111.491,113.643,116.276,122.827,126.892,131.451,132.862,136.927,138.337,142.57,146.635,149.214,151.118,155.518,159.917,164.317,168.717,170.622,173.25,177.65,182.049,184.201,188.601,193.0" y="9.870999999999981" style="fill:#171615;font-family:DPNDFL+AdvOT6e5d2ec0;font-size:7.97px;font-style:NORMAL;font-weight:normal;">Huang et al. Medicine (2018) 97:34 </text>
  <text x="542.723,549.944,554.503,559.317,561.31,565.869,567.861,572.508" y="9.870999999999981" svg_rhmargin="577.067" style="fill:#171615;font-family:DPNDFK+AdvOT34fe1490.B;font-size:7.97px;font-style:NORMAL;font-weight:normal;">Medicine</text>
  <text x="322.243" y="739.625" svg_rhmargin="326.643" style="fill:#171615;font-family:DPNDMJ+AdvOTf94803d4;font-size:7.97px;font-style:NORMAL;font-weight:normal;">2</text>
 </g>
</svg>
